223 related articles for article (PubMed ID: 3861238)
1. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
Yalowich JC; Zucali JR; Gross M; Ross WE
Cancer Res; 1985 Oct; 45(10):4921-4. PubMed ID: 3861238
[TBL] [Abstract][Full Text] [Related]
2. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
Chao NJ; Aihara M; Blume KG; Sikic BI
Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
Lemoli RM; Gulati SC
Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
[TBL] [Abstract][Full Text] [Related]
4. Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture.
Aihara M; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1990 Sep; 18(8):940-4. PubMed ID: 2387345
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 May; 43(5):2267-72. PubMed ID: 6831450
[TBL] [Abstract][Full Text] [Related]
6. Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide.
Cavazzana M; Calvo F; Facchin P; Barreau P; Geny B; Dal Cortivo L; Dresch C
Exp Hematol; 1988 Nov; 16(10):876-83. PubMed ID: 3169155
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
[TBL] [Abstract][Full Text] [Related]
8. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
Ciobanu N; Paietta E; Andreeff M; Papenhausen P; Wiernik PH
Exp Hematol; 1986 Aug; 14(7):626-35. PubMed ID: 3525202
[TBL] [Abstract][Full Text] [Related]
9. Verapamil enhances antitumor activity without increasing myeloid toxicity.
Morrow M; Wait RB; Rosenthal RA; Gamelli RL
Surgery; 1987 Jan; 101(1):63-8. PubMed ID: 3798329
[TBL] [Abstract][Full Text] [Related]
10. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
Jones RJ; Miller CB; Zehnbauer BA; Rowley SD; Colvin OM; Sensenbrenner LL
Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626
[TBL] [Abstract][Full Text] [Related]
13. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
Beck WT; Cirtain MC; Look AT; Ashmun RA
Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
16. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
17. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
Smith MA; Merry S; Smith JG; Kaye SB
Br J Cancer; 1988 Jun; 57(6):576-8. PubMed ID: 3408645
[No Abstract] [Full Text] [Related]
19. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
[TBL] [Abstract][Full Text] [Related]
20. Heat radiosensitization and the level of DNA polymerases alpha and beta of human colony-forming unit-granulocyte-macrophage and myeloid leukemias sensitive and resistant to chemotherapeutic agents.
Mivechi NF; Miyachi H; Scanlon KJ
Cancer Res; 1990 Apr; 50(7):2044-8. PubMed ID: 2317794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
